Skip Navigation
 
The Catalyst

MUSC names new head for Foundation for Research Development

Staff Report

MUSC’s Foundation for Research Development welcomed Michael Rusnak as executive director Oct. 1.

With a diverse background in technology transfer, Rusnak has more than 25 years of life science experience, most recently as director of New Ventures and Technology Development within the technology transfer office at the University of Rochester Medical Center in New York.

In his six-year tenure at Rochester, he led efforts in life science licensing and directed the university’s Technology Development Fund and award process. He established numerous collaborations to foster commercialization, further investments and advance drug discovery, including agreements with the Moulder Center for Drug Discovery Research at Temple University, the Medical Research Council in the United Kingdom, Califia Bio Inc., and Johnson & Johnson.

Previous to Rochester, Rusnak was an entrepreneur-in-residence with BCM Technologies Inc., the venture subsidiary of Baylor College of Medicine, where he was involved in starting and incubating more than five spinoff companies from the medical school.  He held senior positions in biotechnology business development with Ceros Pharmaceuticals, CombiChem and Lexicon Genetics, among others, where he was involved in more than $100 million of partnering activity in the areas of drug discovery, combinatorial chemistry and genomics. Prior to Lexicon he held various positions in marketing, sales and project management with Baxter, Bayer, and Cetus.

Rusnak received his master’s degree in clinical science and lab management from San Francisco State University and has a bachelor’s degree in microbiology from St. Bonaventure University.

October 9, 2013
 
 
 

© 2013  Medical University of South Carolina | Disclaimer